These molecular and antioxidant changes were closely linked with improved glycemic parameters, including fasting glucose, glycosylated hemoglobin (HbA1c), homeostatic model assessment for insulin resistance (HOMA-IR), insulin, and C-peptide. The gene discussed is INS; the disease is Insulin resistance.